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Abstract 
The activity of an ethanolic extract from cocoa bean (Theobroma cacao L.,) towards the non-specific immune response in mice 
being challenged with Staphylococcus epidermidis was studied. Mice (Swiss-Webster, 12 weeks old, 35 ± 1.9 g) received oral 
administration of cocoa extract (CE), positive control or negative control, every day for seven consecutive days. Cocoa extract 
(CE) was in three different doses, i.e. CE1 7.14 mg/30 g body weight (BW), CE2 14.28 mg/30 g BW, and CE3 28.57 mg/30 g 
BW. The positive control was Phyllanthus niruri Linn. (PN) extract (Stimuno®) 17.55 mg/30 g BW, while the negative control 
was sterile water (SW). On day 8, mice were given intraperitoneal injections of S. epidermidis suspension (0.5 ml, 105 CFU). 
After being settled for one hour, mice were sacrificed and peritoneal fluid was withdrawn for staining and microscopy 
observation. The number of macrophages performing phagocytosis and number of bacterial cells being recruited were counted. 
CE increased the number of active macrophages as well as enhanced macrophage phagocytic capacity against S. epidermidis 
cells. Various doses of CE increased the number of active macrophages from 46 ± 5% (SW) to 73 ± 3% (CE1), 76 ± 3% (CE2), 
and 85 ± 12% (CE3). Phagocytic capacity was elevated more than 2-fold after consumption of CE, from 215 ± 25 cells (SW) to 
437 ± 9 cells (CE1), 452 ± 4 cells (CE2), and 511 ± 6 cells (CE3). CE3 with the highest dose had activity equal to that of PN (p = 
0.68; Į = 0.05). This research suggests a potential use of CE as an immunostimulant. This study indicates macrophage activity 
and capacity in mice were enhanced by oral consumption of cocoa extract. 
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1. Introduction 
Cocoa bean as the raw material of chocolate is a very important ingredient for food and beverage preparation. 
The indispensable chocolate flavor has made the demand for cocoa bean continuously increase, with 3% increment 
per year1. Some people have exceptional appreciation of chocolate that the terms of ‘chocoholics’ and ‘chocolate-
craver’ exist2,3. However, with the emerging trend of healthy eating, public perception of chocolate and cocoa 
products may change from ‘enjoyable’ to ‘threatening’. High fat and sugar content attributed to cocoa products have 
induced guilty feelings after eating chocolate.  
Attempts to enhance public perception of cocoa have been focused on health benefit, and accordingly numbers of 
cocoa products have entered the market with various claims. Popular health properties introduced to consumers are 
for cardiovascular protection4, antitussive properties5 and skin perfection6. Two bioactive classes of compounds were 
documented, namely polyphenols and alkaloids. Cocoa polyphenols mainly come from the flavonoid class among 
which (+)-catechin and (–)-epicatechin are dominant compounds. In the other hand, cocoa also contains alkaloids 
(theobromine and caffeine) that have been extensively explored. 
Our previous work reported that cocoa extract inhibited growth of Escherichia coli7 and Shigella dysenteriae8. In 
subsequent research, it was observed that effective doses for in vivo testing were much lower than the theoretical 
dose derived from in vitro evaluation, suggesting cocoa extract may induce the immune response in animals rather 
than directly counteract bacteria cells. This study aimed to explore immunomodulatory properties of cocoa extract, 
with a focus on the non-specific immune response exerted by macrophages in a mouse model. 
2. Methods 
Cococa extract (CE) was prepared from freshly dried cocoa powder (fat removed, unroasted, unfermented) 
extracted using ethanol overnight. The liquid was filtered and was concentrated by using a vacuum evaporator to 
result in CE powder containing 14% catechin (assayed by Folin-Ciocalteu’s reagent9) and 0.6% caffeine (assayed 
using acid-base chromatographic column10). The positive control was syrup of Phyllanthus niruri Linn. extract 
(Stimuno®, DexaMedica). Male Swiss-Webster mice (12 weeks, 30-35 g) were purchased from a local breeder. A 
Staphylococcus epidermidis culture (5 x 105 CFU/ml), chloroform, immersion oil, phosphate buffered saline, and 
Giemsa stain were provided by the Microbiology Laboratory, Faculty of Medicine, Jember University. 
Mice were acclimatized for at least one week while receiving feed and water ad libitum. Twenty mice were 
distributed into 5 groups, 3 groups of treatment, positive control and negative control group. Treatment groups 
receiving different doses of CE, i.e. 7.14 mg/30 g body weight (BW) (CE1), 14.28 mg/30 g BW (CE2), and 28.56/30 
g BW (CE3). The positive control group received 17.55 mg/30 g BW of Phyllanthus niruri Linn. extract (PN) and 
negative control consumed sterile water (SW). Test samples were delivered through oral administration once a day 
for 7 days. On day 8, S. epidermidis culture was injected intraperitoneally, and after one hour of settlement mice 
were sacrificed. Intraperitoneal fluid was obtained and processed for fixation and staining prior to microscopic 
observation. This study has been approved for ethical clearance by the Committee from Faculty of Medicine, Jember 
University. 
Data analysis employed Minitab 14 and SPSS 22 for Windows statistical software for testing normal distribution, 
homogeneity and one-way analysis of variance (ANOVA). Significant difference between groups was evaluated 
using post-hoc Duncan’s test to determine the p value with Į = 0, 05. 
3. Results and discussion 
The effect of oral administration of SW, PN and CE in Swiss-Webster male mice for seven consecutive days was 
evaluated from the number of active macrophages per hundred total macrophages (%). The negative control group 
consuming sterile water (SW) had 46 ± 5% active macrophages. In the other hand, the PN group had a greater 
number of active macrophages, 80 ± 4%. PN extract has been studied for immunomodulatory properties, particularly 
in stimulating macrophage activity and T-lymphocyte proliferation11.  
After consumption of CE1, the active macrophage number was improved to 73 ± 3%. Higher concentration in 
CE2 and CE3 resulted in proportions of active macrophages of 76 ± 3% and 85 ± 12%, respectively, which were not 
significantly different compared to CE1. This indicates improvement of CE in macrophage activation did not occur 
in a dose-dependent manner at these (high) doses. However, since CE1 did not show a significantly different result 
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than PN, it was suggested that a comparable effect may be exerted by CE at the lowest dose of 7.14 mg/30 g BW 
(Fig. 1). 
In addition to determining active macrophage numbers, the number of bacterial cells being recruited by 
macrophages during phagocytosis was evaluated as the phagocytic capacity of macrophages. Baseline phagocytic 
capacity in the untreated group (SW) was 216 ± 25 bacteria/50 macrophages. This was improved dramatically in the 
PN group to 506 ± 12 bacteria/50 macrophages. Improvement was also observed after administration of CE, which 
in the lowest dose produced high phagocytic capacity (437 ± 9). The effects of CE1 (437 ± 9) and CE2 (452 ± 4) 
were not significantly different (p = 0.199, Į = 0.05), but CE3 (511 ± 6) produced a significantly higher effect. 
Administration of CE3 resulted in an effect comparable to that of PN (p = 0.68, Į = 0.05) (Fig. 2). 
 
 
 
Fig. 1. Percentage of active macrophage in intraperitoneal fluid following administration of sterile water (SW), CE dose 1 (CE1), dose 2 (CE2), 
dose 3 (CE3), and Phyllanthus niruri Linn. extract (PN).
 
 
Fig. 2. Phagocytic capacity of macrophages expressed as number of S. epidermidis cells recruited per fifty active macrophages, following administration of sterile 
water (SW), CE dose 1 (CE1), dose 2 (CE2), dose 3 (CE3), and Phyllanthus niruri Linn. extract (PN).
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The dose variations used in this study can be considered relative to the catechin content in CE. The lowest dose in 
CE1 (7.14 mg) was estimated to contain 1.0 mg catechin, while CE2 and CE3 delivered 2.0 mg and 4.0 mg catechin, 
respectively. When the catechin content in CE is extrapolated to a human dose, consumption of CE1 will represent 
187 mg catechin intake by a human with body weight 70 kg, hence CE2 and CE3 will deliver 376 mg and 755 mg of 
catechin, respectively. The catechin amount is consistent with human studies that reported the effective catechin 
intake for health improvement. 
A study by Grassi et al.4 reported consumption of dark chocolate containing 500 mg flavanol lowered the blood 
glucose level and enhanced insulin sensitivity of human subjects. This condition was observed after a relatively 
short term administration for 7 days. In another study, Desideri et al.12 suggested that cocoa flavanol intake of 990 
mg/day for 8 weeks contributed to cognitive improvement in 90 elderly individuals with mild cognitive impairment. 
A moderate intake of cocoa flavanol (550 mg/day) brought a similar effect to that of high flavanol treatment. 
However, a low intake (45 mg/day) resulted in no significant improvement in trail making and verbal fluency tests. 
The trail making test is used to evaluate visual-conceptual and visual-tracking ability while indicating visual 
processing impairment due to brain damage. These two studies indicated the effective cocoa flavanol intake 
(represented by catechin) is around 500 mg/day. 
With regards to the immune system, Ramiro-Puig and Castell13 have proposed cocoa polyphenols to be the 
immunomodulators. Cocoa consumption may affect the immune system in three aspects, i.e. composition, activity 
and response of immune cells. Mice receiving a cocoa-rich diet underwent alteration of lymphocyte composition in 
the intestine, particularly in Peyer’s patches and mesenteric lymph nodes. In addition, both tissues had increasing 
amounts of T-cell-antigen receptor14. Activity of immune cells was also affected by cocoa consumption, whereas 
lymphocytes exhibited reduced immunoglobulin-A secretion14. Incubation of EL4.BU.OU6 cell lines with cocoa 
catechin resulted in a decreas in IL-2 receptor Į (CD25) expression and IL-2 secretions, while IL-4 production was 
enhanced15.  
Macrophage activity and phagocytic capacity following CE administration showed that a low catechin intake 
may bring significant improvement in the non-specific immune response. The lowest dose of CE administration 
(7.14 mg/30 g BW, representing 1.0 mg/30 g BW catechin) was sufficient to successfully stimulate macrophage 
activity as well as phagocytic capacity. Moreover, the higher catechin intake to 4.0 mg/30 g BW had comparable 
effects to that of PN as the positive control. This research agreed with previous studies on immunomodulatory 
properties of cocoa. 
4. Conclusion 
Oral consumption of CE may stimulate non-specific immune responses in adult mice challenged by S.
epidermidis. This effect was observed after daily administration for seven days. The highest CE dose, delivering 4 
mg/30 g BW catechin demonstrated desirable stimulation in terms of active macrophage number and phagocytic 
capacity.  
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